GL1X · GenesisL1 explorer

Research workbench

Shv-1 in complex with 4H-PYRAZOLO[1,5-C][1,3]THIAZOLE containing penem inhibitor

Analyse Shv-1 in complex with 4H-PYRAZOLO[1,5-C][1,3]THIAZOLE containing penem inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GDB
Type
protein
Length
265 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase shv-1
EC
3.5.2.6
UniProt
P0AD64
Ligands
MA4, 17O
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase shv-1 (EC 3.5.2.6)protein26545% helix, 17% strandP0AD64

Ligands and binding sites

  • MA4 · Cyclohexyl-hexyl-beta-D-maltoside · ligand · 2 copies · chains A
  • 17O · (7R)-6-formyl-7-(4H-pyrazolo[1,5-c][1,3]thiazol-2-yl)-4,7-dihydro-1,4-thiazepine-3-carboxylic acid · ligand · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12010.690.8623MA4

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 4GDB · SHV-1 in complex with 4H-pyrazolo[1,5-c][1,3]thiazole containing penem inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P0AD64 · AlphaFold monomer V2.0 prediction for beta-lactamase shv-1 (P0AD64) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.